Using interferon-beta to combat cancer stem cell properties in triple negative breast cancer

Oncoscience. 2018 Jun 28;5(5-6):169-171. doi: 10.18632/oncoscience.438. eCollection 2018 May.

Authors

Mary R Doherty¹, Mark W Jackson¹

Affiliation

¹ Department of Pathology, Case Western Reserve University, School of Medicine, Cleveland, OH 44106, USA; bCase Comprehensive Cancer Center, Case Western Reserve University, School of Medicine, Cleveland, OH 44106, USA.

No abstract available

Keywords: cancer stem cells; cellular plasticity; interferon-beta; triple-negative breast cancer.

Publication types

Editorial

Grants and funding